clofibric acid has been researched along with Leukemia, Myeloid in 1 studies
Clofibric Acid: An antilipemic agent that is the biologically active metabolite of CLOFIBRATE.
clofibric acid : A monocarboxylic acid that is isobutyric acid substituted at position 2 by a p-chlorophenoxy group. It is a metabolite of the drug clofibrate.
Leukemia, Myeloid: Form of leukemia characterized by an uncontrolled proliferation of the myeloid lineage and their precursors (MYELOID PROGENITOR CELLS) in the bone marrow and other sites.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Scatena, R | 1 |
| Nocca, G | 1 |
| Sole, PD | 1 |
| Rumi, C | 1 |
| Puggioni, P | 1 |
| Remiddi, F | 1 |
| Bottoni, P | 1 |
| Ficarra, S | 1 |
| Giardina, B | 1 |
1 other study available for clofibric acid and Leukemia, Myeloid
| Article | Year |
|---|---|
Bezafibrate as differentiating factor of human myeloid leukemia cells.
Topics: Acetylcysteine; Antineoplastic Agents; Antioxidants; Bezafibrate; Biomarkers; Cell Cycle; Cell Diffe | 1999 |